Market Overview:
The global pantoprazole injection market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The hospital segment is expected to hold the dominant share in the global pantoprazole injection market, by application, in 2018. North America is estimated to be the leading region for the global pantoprazole injection market in 2018. Asia Pacific is projected to be the fastest growing region for the global pantoprazole injection market during the forecast period. Some of key factors driving growth of this market include increasing prevalence of gastrointestinal disorders and rising demand for proton pump inhibitors (PPIs) drugs across globe. Additionally, increasing number of hospitals and clinics are offering proton pump inhibitors therapy as an effective treatment option for various gastrointestinal disorders which would further fuel growth of this market over next few years.
Product Definition:
Pantoprazole injection is a proton pump inhibitor used to treat gastroesophageal reflux disease, erosive esophagitis, and Zollinger-Ellison Syndrome. Pantoprazole injection is also used to prevent and treat gastric ulcers caused by Helicobacter pylori infection.
40mg:
40mg is used for the treatment of erosive esophagitis, Zollinger-Ellison syndrome, and gastric ulcer. The drug has also been found to be effective in treating heartburn associated with acid reflux disease. It reduces stomach acids production which can lead to damage to the cells that line the inner surface of the stomach and upper intestine.
60mg:
60 mg is used for the treatment of erosive esophagitis, Zollinger-Ellison syndrome, and gastric ulcer. It is also used in prophylaxis of acid reflux disease in patients suffering from H. pylori infection.
Pantoprazole Injection (PPZ) is a medicine that reduces stomach acid production by blocking the H+/K+ pump that normally acts to maintain pH balance in the stomach.
Application Insights:
The hospital application segment led the global pantoprazole injection market in 2017 and is projected to witness significant growth over the forecast period. The recovery center application segment is expected to register a high CAGR of XX% during the study period owing to increasing number of patients with gastroesophageal reflux disease (GERD) seeking treatment at such centers.
Hospital applications accounted for more than 60% share in terms of revenue in 2017 due to rising prevalence of heartburn and indigestion among consumers globally. Moreover, growing awareness about lifestyle disorders coupled with an increase in health care expenditure will boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global pantoprazole injection market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing R&D activities, presence of key players and high adoption rate for new technologies across this region.
In Asia Pacific, pantoprazole tablets are widely used for treatment or prevention purposes owing to increasing awareness about early diagnosis among patients; availability & accessibility to healthcare providers; improvement in infrastructure facilities including hospitals & clinics; and rise in disposable income especially among middle-class population groups which enables them access better quality medical treatments at lower costs than before.
Growth Factors:
- Increasing incidence of gastrointestinal disorders: The increasing incidence of gastrointestinal disorders, such as peptic ulcer, gastritis, and GERD is expected to drive the demand for pantoprazole injection in the coming years.
- Growing awareness about proton pump inhibitors: There is a growing awareness among people about proton pump inhibitors and their benefits over other types of medications for treating gastrointestinal disorders. This is likely to boost the demand for pantoprazole injection in the near future.
- Rising number of hospital admissions: The rising number of hospital admissions due to gastrointestinal problems is anticipated to create a high demand for pantoprazole injection in the coming years.
- Technological advancements in drug delivery systems: The technological advancements in drug delivery systems are expected to play a key role in driving the growth of the pantoprazole injection market during the forecast period. These advancements are making it easier and more convenient for patients to take medication through injections instead oral pills or capsules, thereby boosting market growth significantly. 5) Availability of generic versions at affordable prices: Pantoprazole injection is available as a generic drug at affordable prices, which makes it more accessible and affordable than branded drugs available in developed countries such as America and Europe
Scope Of The Report
Report Attributes
Report Details
Report Title
Pantoprazole Injection Market Research Report
By Type
40mg, 60mg
By Application
Hospital, Special Clinic, Recovery Center
By Companies
AuroMedics, Hikma, Pfizer, Sun Pharma, Aristo Pharmaceuticals, Abbot, Wellona Pharma, Taj Pharma, Cipla, Beijing Sihuan Pharm, Reyoung Pharm, Jinzhou Jiutai Pharmaceutical, Shenyang Guangda Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Pantoprazole Injection Market Report Segments:
The global Pantoprazole Injection market is segmented on the basis of:
Types
40mg, 60mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Special Clinic, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AuroMedics
- Hikma
- Pfizer
- Sun Pharma
- Aristo Pharmaceuticals
- Abbot
- Wellona Pharma
- Taj Pharma
- Cipla
- Beijing Sihuan Pharm
- Reyoung Pharm
- Jinzhou Jiutai Pharmaceutical
- Shenyang Guangda Pharmaceutical
Highlights of The Pantoprazole Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 40mg
- 60mg
- By Application:
- Hospital
- Special Clinic
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pantoprazole Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pantoprazole injection is a medication used to treat gastroesophageal reflux disease (GERD). Pantoprazole injection is a long-acting form of the drug that is given by IV.
Some of the key players operating in the pantoprazole injection market are AuroMedics, Hikma, Pfizer, Sun Pharma, Aristo Pharmaceuticals, Abbot, Wellona Pharma, Taj Pharma, Cipla, Beijing Sihuan Pharm, Reyoung Pharm, Jinzhou Jiutai Pharmaceutical, Shenyang Guangda Pharmaceutical.
The pantoprazole injection market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pantoprazole Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pantoprazole Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pantoprazole Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pantoprazole Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pantoprazole Injection Market Size & Forecast, 2020-2028
4.5.1 Pantoprazole Injection Market Size and Y-o-Y Growth
4.5.2 Pantoprazole Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 40mg
5.2.2 60mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Special Clinic
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pantoprazole Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pantoprazole Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 40mg
9.6.2 60mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Special Clinic
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 40mg
10.6.2 60mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Special Clinic
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 40mg
11.6.2 60mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Special Clinic
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 40mg
12.6.2 60mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Special Clinic
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 40mg
13.6.2 60mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Special Clinic
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pantoprazole Injection Market: Competitive Dashboard
14.2 Global Pantoprazole Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AuroMedics
14.3.2 Hikma
14.3.3 Pfizer
14.3.4 Sun Pharma
14.3.5 Aristo Pharmaceuticals
14.3.6 Abbot
14.3.7 Wellona Pharma
14.3.8 Taj Pharma
14.3.9 Cipla
14.3.10 Beijing Sihuan Pharm
14.3.11 Reyoung Pharm
14.3.12 Jinzhou Jiutai Pharmaceutical
14.3.13 Shenyang Guangda Pharmaceutical
